Preoperative Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Not Clinically Useful in Predicting Prognosis in Early Stage Cervical Cancer

Table 2

Clinicopathological characteristics according to platelet/lymphocyte ratio.

Variable	n (%) ()	Platelet/lymphocyte ratio		value
		≤119 ()	>119 ()
Age				0.270
<50 years	162 (35.2)	87 (37.7)	75 (32.8)
≥50 years	298 (64.8)	144 (62.3)	154 (67.2)
Stage				0.537
IA2	42 (9.1)	23 (10.0)	19 (8.3)
IB1	418 (90.9)	208 (90.0)	210 (91.7)
Histology				0.711
Squamous carcinoma	268 (58.3)	129 (55.9)	139 (60.7)
Adenocarcinoma	153 (33.2)	80 (34.6)	73 (31.9)
Adenosquamous carcinoma	26 (5.7)	15 (6.5)	11 (4.8)
Others	13 (2.8)	7 (3.0)	6 (2.6)
Tumor size				0.574
≤2 cm	309 (67.2)	158 (68.4)	151 (65.9)
>2 cm	151 (32.8)	73 (31.6)	78 (34.1)
Lymph vascular space invasion				0.627
No	346 (75.2)	176 (76.2)	170 (74.2)
Yes	114 (24.8)	55 (23.8)	59 (25.8)
Deep stromal invasion				0.222
No	339 (73.7)	176 (76.2)	163 (71.2)
Yes	121 (26.3)	55 (23.8)	66 (28.8)
Parametrial involvement				0.470
No	441 (95.9)	223 (96.5)	218 (95.2)
Yes	19 (4.1)	8 (3.5)	11 (4.8)
Lymph node status				0.691
No	436 (94.8)	218 (94.4)	218 (95.2)
Yes	24 (5.2)	13 (5.6)	11 (4.8)
Vaginal margin				0.617
No	442 (96.1)	223 (96.5)	219 (95.6)
Yes	18 (3.9)	8 (3.5)	10 (4.4)
Adjuvant treatment				0.033
No	366 (79.6)	193 (83.5)	173 (75.5)
Yes	94 (20.4)	38 (16.5)	56 (24.5)